Aim & Scope
Biopharma Dealmakers is a print and digital publication that showcases active partnering companies and their opportunities across the biopharma industry. Each issue focuses on up to four therapeutic or technology themes. Each theme is led by an editorial feature that explores the dealmaking or landscape trends, which is then aligned with a collection of profiles of biopharma companies developing new innovations in the same area of interest. Designed to assist an industry that is driven by dealmaking, Biopharma Dealmakers was established in 2007 to provide a dedicated and go-to platform for biotech and pharmaceutical companies to share and showcase their emerging drug candidates and technologies to potential partners. The publication is aimed at pharmaceutical, biotech, medtech and academic organizations as well as investors, non-profit organizations and start-ups all seeking partnerships. Sign up for regular content alerts and digital editions. Core therapeutic and technology themes covered • Antibody technologies; • Autoimmune diseases; • Cardiovascular diseases; • Cell and gene therapies; • Central nervous system disorders; • Dermatology; • Diagnostics; • Drug development; • Gastrointestinal diseases; • Infectious diseases; • Medtech; • Metabolic diseases; • Oncology including immuno-oncology; • Precision medicine. [1]